Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Unlocking InhA: Novel approaches to inhibit Mycobacterium tuberculosis.
Bioorg Chem. 2024 May;146:107250. doi: 10.1016/j.bioorg.2024.107250. Epub 2024 Mar 5.
Bioorg Chem. 2024.
PMID: 38460337
Review.
Novel VEGFR-2 Kinase Inhibitors as Anticancer Agents: A Review Focusing on SAR and Molecular Docking Studies (2016-2021).
S V, Kajal K, Mondal S, Wahan SK, Das Kurmi B, Das Gupta G, Patel P.
S V, et al. Among authors: wahan sk.
Chem Biodivers. 2023 Feb;20(2):e202200847. doi: 10.1002/cbdv.202200847. Epub 2023 Jan 31.
Chem Biodivers. 2023.
PMID: 36721068
Review.
Item in Clipboard
Anti-Tubercular Activity of Pyrazinamide Conjugates: Synthesis and Structure-Activity Relationship Studies.
Wahan SK, Sharma S, Chawla PA.
Wahan SK, et al.
Mini Rev Med Chem. 2023;23(6):700-718. doi: 10.2174/1389557522666220819092431.
Mini Rev Med Chem. 2023.
PMID: 35986542
Review.
Item in Clipboard
Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent.
Patel P, Wahan SK, Vishakha S, Kurmi BD, Gupta GD, Rajak H, Asati V.
Patel P, et al. Among authors: wahan sk.
Curr Cancer Drug Targets. 2022;23(1):47-70. doi: 10.2174/1568009622666220624090542.
Curr Cancer Drug Targets. 2022.
PMID: 35747969
Review.
Item in Clipboard
Cite
Cite